CART-BCMA/CS1
/ UCLA Jonsson Comprehensive Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 01, 2024
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Jonsson Comprehensive Cancer Center | N=30 ➔ 0 | Not yet recruiting ➔ Withdrawn
Enrollment change • IO biomarker • Trial withdrawal • Hematological Malignancies • Multiple Myeloma • Oncology
December 15, 2023
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Jonsson Comprehensive Cancer Center | Trial completion date: Dec 2027 ➔ Mar 2028 | Initiation date: Dec 2023 ➔ Mar 2024 | Trial primary completion date: Dec 2026 ➔ Mar 2027
IO biomarker • Trial completion date • Trial initiation date • Trial primary completion date • Hematological Malignancies • Multiple Myeloma • Oncology
July 20, 2023
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Jonsson Comprehensive Cancer Center
IO biomarker • New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 3
Of
3
Go to page
1